297 related articles for article (PubMed ID: 26414019)
1. Areca nut alkaloids induce irreparable DNA damage and senescence in fibroblasts and may create a favourable environment for tumour progression.
Rehman A; Ali S; Lone MA; Atif M; Hassona Y; Prime SS; Pitiyage GN; James EL; Parkinson EK
J Oral Pathol Med; 2016 May; 45(5):365-72. PubMed ID: 26414019
[TBL] [Abstract][Full Text] [Related]
2. Role of Areca Nut Induced TGF-β and Epithelial-Mesenchymal Interaction in the Pathogenesis of Oral Submucous Fibrosis.
Pant I; Kumar N; Khan I; Rao SG; Kondaiah P
PLoS One; 2015; 10(6):e0129252. PubMed ID: 26107172
[TBL] [Abstract][Full Text] [Related]
3. Activation of TGF-β pathway by areca nut constituents: a possible cause of oral submucous fibrosis.
Khan I; Kumar N; Pant I; Narra S; Kondaiah P
PLoS One; 2012; 7(12):e51806. PubMed ID: 23284772
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms of Malignant Transformation of Oral Submucous Fibrosis by Different Betel Quid Constituents-Does Fibroblast Senescence Play a Role?
Zhang P; Chua NQE; Dang S; Davis A; Chong KW; Prime SS; Cirillo N
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163557
[TBL] [Abstract][Full Text] [Related]
5. Senescent mesenchymal cells accumulate in human fibrosis by a telomere-independent mechanism and ameliorate fibrosis through matrix metalloproteinases.
Pitiyage GN; Slijepcevic P; Gabrani A; Chianea YG; Lim KP; Prime SS; Tilakaratne WM; Fortune F; Parkinson EK
J Pathol; 2011 Apr; 223(5):604-17. PubMed ID: 21341274
[TBL] [Abstract][Full Text] [Related]
6. Areca nut-induced buccal mucosa fibroblast contraction and its signaling: a potential role in oral submucous fibrosis--a precancer condition.
Chang MC; Lin LD; Wu HL; Ho YS; Hsien HC; Wang TM; Jeng PY; Cheng RH; Hahn LJ; Jeng JH
Carcinogenesis; 2013 May; 34(5):1096-104. PubMed ID: 23349021
[TBL] [Abstract][Full Text] [Related]
7. Progression of genotype-specific oral cancer leads to senescence of cancer-associated fibroblasts and is mediated by oxidative stress and TGF-β.
Hassona Y; Cirillo N; Lim KP; Herman A; Mellone M; Thomas GJ; Pitiyage GN; Parkinson EK; Prime SS
Carcinogenesis; 2013 Jun; 34(6):1286-95. PubMed ID: 23358854
[TBL] [Abstract][Full Text] [Related]
8. Epithelial atrophy in oral submucous fibrosis is mediated by copper (II) and arecoline of areca nut.
Khan I; Pant I; Narra S; Radhesh R; Ranganathan K; Rao SG; Kondaiah P
J Cell Mol Med; 2015 Oct; 19(10):2397-412. PubMed ID: 26248978
[TBL] [Abstract][Full Text] [Related]
9. Areca nut extract-treated gingival fibroblasts modulate the invasiveness of polymorphonuclear leukocytes via the production of MMP-2.
Lu HH; Chen LK; Cheng CY; Hung SL; Lin SC; Chang KW
J Oral Pathol Med; 2009 Jan; 38(1):79-86. PubMed ID: 19192053
[TBL] [Abstract][Full Text] [Related]
10. Arecoline, a major alkaloid of areca nut, inhibits p53, represses DNA repair, and triggers DNA damage response in human epithelial cells.
Tsai YS; Lee KW; Huang JL; Liu YS; Juo SH; Kuo WR; Chang JG; Lin CS; Jong YJ
Toxicology; 2008 Jul; 249(2-3):230-7. PubMed ID: 18585839
[TBL] [Abstract][Full Text] [Related]
11. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
Moutasim KA; Jenei V; Sapienza K; Marsh D; Weinreb PH; Violette SM; Lewis MP; Marshall JF; Fortune F; Tilakaratne WM; Hart IR; Thomas GJ
J Pathol; 2011 Feb; 223(3):366-77. PubMed ID: 21171082
[TBL] [Abstract][Full Text] [Related]
12. Fibrotic Effects of Arecoline N-Oxide in Oral Potentially Malignant Disorders.
Kuo TM; Luo SY; Chiang SL; Yeh KT; Hsu HT; Wu CT; Lu CY; Tsai MH; Chang JG; Ko YC
J Agric Food Chem; 2015 Jun; 63(24):5787-94. PubMed ID: 26061808
[TBL] [Abstract][Full Text] [Related]
13. Panax notoginseng saponins inhibit areca nut extract-induced oral submucous fibrosis in vitro.
Dai JP; Chen XX; Zhu DX; Wan QY; Chen C; Wang GF; Li WZ; Li KS
J Oral Pathol Med; 2014 Jul; 43(6):464-70. PubMed ID: 24484214
[TBL] [Abstract][Full Text] [Related]
14. Toxicity of areca nut ingredients: activation of CHK1/CHK2, induction of cell cycle arrest, and regulation of MMP-9 and TIMPs production in SAS epithelial cells.
Chang MC; Chan CP; Wang WT; Chang BE; Lee JJ; Tseng SK; Yeung SY; Hahn LJ; Jeng JH
Head Neck; 2013 Sep; 35(9):1295-302. PubMed ID: 22907745
[TBL] [Abstract][Full Text] [Related]
15. Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 (TIMPs -1 and -2) in fibroblasts are early indicators of oral sub-mucous fibrosis and ageing.
Pitiyage GN; Lim KP; Gemenitzidis E; Teh MT; Waseem A; Prime SS; Tilakaratne WM; Fortune F; Parkinson EK
J Oral Pathol Med; 2012 Jul; 41(6):454-62. PubMed ID: 22385081
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Tanshinone IIA, salvianolic acid A and salvianolic acid B on Areca nut extract-induced oral submucous fibrosis in vitro.
Dai JP; Zhu DX; Sheng JT; Chen XX; Li WZ; Wang GF; Li KS; Su Y
Molecules; 2015 Apr; 20(4):6794-807. PubMed ID: 25884554
[TBL] [Abstract][Full Text] [Related]
17. Arecoline N-oxide: its mutagenicity and possible role as ultimate carcinogen in areca oral carcinogenesis.
Lin KH; Lin CY; Liu CC; Chou MY; Lin JK
J Agric Food Chem; 2011 Apr; 59(7):3420-8. PubMed ID: 21370913
[TBL] [Abstract][Full Text] [Related]
18. Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis.
Chang YC; Yang SF; Tai KW; Chou MY; Hsieh YS
Oral Oncol; 2002 Feb; 38(2):195-200. PubMed ID: 11854068
[TBL] [Abstract][Full Text] [Related]
19. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
Shieh DH; Chiang LC; Shieh TY
Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
[TBL] [Abstract][Full Text] [Related]
20. Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
J Oral Pathol Med; 2005 Feb; 34(2):100-5. PubMed ID: 15641989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
